[Transdermal buprenorphine for acute postoperative pain: a systematic review].
Sign Up to like & getrecommendations! Published in 2020 at "Revista brasileira de anestesiologia"
DOI: 10.1016/j.bjan.2020.04.004
Abstract: BACKGROUND AND OBJECTIVES Postoperative pain is still a major concern in several surgical procedures. Multimodal analgesia is best for postoperative pain management; however, opioid therapy is still the main treatment for pain after surgical procedures.… read more here.
Keywords: postoperative pain; transdermal buprenorphine; acute postoperative; pain ... See more keywords
Transdermal buprenorphine for moderate chronic noncancer pain syndromes
Sign Up to like & getrecommendations! Published in 2018 at "Expert Review of Neurotherapeutics"
DOI: 10.1080/14737175.2018.1462701
Abstract: ABSTRACT Introduction: Chronic noncancer pain has remained a challenging clinical problem. Opioid analgesics are effective, but they are known to be associated with opioid use disorder and potentially treatment-limiting side effects. Buprenorphine is a Schedule… read more here.
Keywords: transdermal buprenorphine; noncancer pain; pain; chronic noncancer ... See more keywords
Transdermal buprenorphine for in-hospital transition from full agonist opioids to sublingual buprenorphine: a retrospective observational cohort study
Sign Up to like & getrecommendations! Published in 2022 at "Clinical Toxicology"
DOI: 10.1080/15563650.2022.2028802
Abstract: Abstract Introduction Patients with opioid use disorder may have difficulty transitioning from full-agonist opioids to sublingual buprenorphine due to the risk of precipitated opioid withdrawal. Novel strategies have been developed to facilitate this transition, including… read more here.
Keywords: sublingual buprenorphine; transdermal buprenorphine; buprenorphine; full agonist ... See more keywords
48-hour Induction of Transdermal Buprenorphine to Sublingual Buprenorphine/Naloxone: The IPPAS Method.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of addiction medicine"
DOI: 10.1097/adm.0000000000001072
Abstract: Buprenorphine is an effective medication for the treatment of opioid use disorder. However, the traditional method of buprenorphine induction requires a period of abstinence and the development of at least moderate withdrawal, which can be… read more here.
Keywords: sublingual buprenorphine; transdermal buprenorphine; buprenorphine; buprenorphine naloxone ... See more keywords
Transdermal buprenorphine improves overall quality of life and symptom severity in cancer patients with pain.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of clinical nursing"
DOI: 10.1111/jocn.16303
Abstract: AIM AND OBJECTIVES This study explored the effect of transdermal buprenorphine on quality of life and six symptoms in cancer patients with pain. BACKGROUND Transdermal opioids offer advantages over traditional routes of administration. The impact… read more here.
Keywords: cancer; quality life; transdermal buprenorphine; quality ... See more keywords
Margin of safety of extended-duration transdermal buprenorphine solution following multiple-dose administrations to cats.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of veterinary pharmacology and therapeutics"
DOI: 10.1111/jvp.13051
Abstract: Transdermal buprenorphine solution (TBS) is approved for the control of postoperative pain in cats where a single preoperative dose provides 4 days of analgesia. It is administered as a unit dose of 8 mg to cats weighing… read more here.
Keywords: safety; transdermal buprenorphine; buprenorphine solution; dosing interval ... See more keywords